Accelerated Tumor Growth Mediated by Sublytic Levels of Antibody-Induced Complement Activation Is Associated With Activation of the PI3K/AKT Survival Pathway
Clinical Cancer Research - United States
doi 10.1158/1078-0432.ccr-13-0088
Full Text
Open PDFAbstract
Available in full text
Date
July 5, 2013
Authors
Publisher
American Association for Cancer Research (AACR)